ストックスクリーナーアプリを入手
9.48
4.52%
0.41
プレマーケット:
9.84
0.36
+3.80%
Leonabio Inc (LONA) 最新ニュース
28,000-share stock option grant to LeonaBio (LONA) director - Stock Titan
LeonaBio (LONA) awards 300,000 stock options to chief scientific officer - Stock Titan
28,000 stock options granted to LeonaBio (LONA) director Kosacz - Stock Titan
LeonaBio (LONA) director Grant Pickering receives 28,000 stock options - Stock Titan
Director Romano Kelly receives 28,000 LeonaBio (LONA) stock options at $9.54 - Stock Titan
LeonaBio (LONA) director receives options to buy 28,000 shares at $9.54 - Stock Titan
LeonaBio (LONA) director awarded options on 28,000 shares at $9.54 - Stock Titan
LeonaBio (LONA) grants CMO 350,000 options at $9.54 - Stock Titan
Director John M. Fluke Jr. receives 28,000-share option grant at LeonaBio (LONA) - Stock Titan
LeonaBio (LONA) awards 300,000 stock options to general counsel - Stock Titan
LeonaBio (LONA) CFO awarded 300,000 stock options at $9.54 - Stock Titan
LeonaBio (LONA) CEO awarded 750,000 stock options at $9.54 strike - Stock Titan
LONA: LeonaBio, Inc.Comparison to Industry - Zacks Investment Research
Leonabio discovers new pannexin-1 inhibitors - BioWorld News
LONA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Cantor Fitzgerald reiterates Overweight on LeonaBio stock By Investing.com - Investing.com Canada
Cantor Fitzgerald reiterates Overweight on LeonaBio stock - Investing.com
Mizuho raises LeonaBio stock price target to $16 on breast cancer drug outlook By Investing.com - Investing.com South Africa
Mizuho raises LeonaBio stock price target to $16 on breast cancer drug outlook - Investing.com India
Mizuho Raises Price Target on LeonaBio to $16 From $10, Keeps Outperform Rating - marketscreener.com
[EFFECT] LeonaBio, Inc. SEC Filing - Stock Titan
Leonabio Warns of Major Financial and Operational Risks in Lasofoxifene Program Integration - TipRanks
LeonaBio (ATHA) clears resale of 5.5M warrant shares for Sermonix - Stock Titan
LeonaBio (NASDAQ: LONA) files resale registration for PIPE warrant holders - Stock Titan
LeonaBio (NASDAQ: ATHA) leans on breast cancer and ALS drugs - Stock Titan
LeonaBio (NASDAQ: ATHA) expands Sermonix deal disclosure and ELAINE-3 trial spend - Stock Titan
LeonaBio Inc reports results for the quarter ended December 31Earnings Summary - TradingView
LeonaBio Reports 2025 Financial Results, Acquires Lasofoxifene License, and Advances Clinical Pipeline for Metastatic Breast Cancer and ALS 123 - Minichart
LeonaBio Updates Investors on 2025 Results and Strategy - TipRanks
LeonaBio (NASDAQ: LONA) boosts cash to fund Phase 3 breast cancer drug - Stock Titan
LeonaBio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
LeonaBio, Inc. announced that it has received $89.724073 million in funding - MarketScreener
LeonaBio (LONA) Stock Analysis Report | Financials & Insights - Benzinga Japan
LeonaBio, Inc. Adopts 2026 Equity Incentive Plan and Amends Certificate of Incorporation – SEC 8-K Filing March 2026 - Minichart
LeonaBio shareholders approve equity plan and increase in authorized shares - Investing.com India
Form 8K LeonaBio Inc For: 19 March - Investing.com
LeonaBio Expands Share Authorization to Support Future Financing - TipRanks
LeonaBio (ATHA) wins approval for 2026 equity plan and major share increase - Stock Titan
LeonaBio, Inc. (prev. ATHA) (LONA) Stock Price Prediction for 2026, 2030-2040 - Traders Union
[DEFR14A] LeonaBio, Inc. Revised Proxy Statement - Stock Titan
Renninger, LeonaBio CFO, sells $4.9k in LONA stock - Investing.com Nigeria
LeonaBio CEO Litton sells $27,687 in shares By Investing.com - Investing.com India
LeonaBio CEO Litton sells $27,687 in shares - Investing.com South Africa
Renninger, LeonaBio CFO, sells $4.9k in LONA stock By Investing.com - Investing.com Canada
LeonaBio (ATHA) counsel sells 1,328 shares to cover RSU tax bill - Stock Titan
LeonaBio (LONA) CMO covers RSU tax bill with share sale - Stock Titan
2.69%
0.25%
大文字化:
|
ボリューム (24 時間):